When is a medicine unwanted, how is it disposed, and how might safe disposal be promoted? Insights from the Australian population

2018 ◽  
Vol 42 (6) ◽  
pp. 709 ◽  
Author(s):  
Emilie Bettington ◽  
Jean Spinks ◽  
Fiona Kelly ◽  
Alejandra Gallardo-Godoy ◽  
Son Nghiem ◽  
...  

Objective The aim of the present study was to explore disposal practices of unwanted medicines in a representative sample of Australian adults, compare this with previous household waste surveys and explore awareness of the National Return and Disposal of Unwanted Medicines (RUM) Project. Methods A 10-min online survey was developed, piloted and conducted with an existing research panel of adult individuals. Survey questions recorded demographics, the presence of unwanted medicines in the home, medicine disposal practices and concerns about unwanted medicines. Descriptive statistical analyses and rank-ordered logit regression were conducted. Results Sixty per cent of 4302 respondents reported having unwanted medicines in their household. Medicines were primarily kept just in case they were needed again and one-third of these medicines were expired. Two-thirds of respondents disposed of medicines with the household garbage and approximately one-quarter poured medicines down the drain. Only 17.6% of respondents had heard of the RUM Project, although, once informed, 91.7% stated that they would use it. Respondents ranked the risk of unintended ingestion as the most important public health message for future social marketing campaigns. Conclusions Respondents were largely unaware of the RUM Project, yet were willing to use it once informed. Limited awareness could lead to environmental or public health risks, and targeted information campaigns are needed. What is known about the topic? There is a growing international evidence base on how people dispose of unwanted medicines and the negative consequences, particularly the environmental effects of inappropriate disposal. Although insight into variation in disposal methods is increasing, knowledge of how people perceive risks and awareness of inappropriate disposal methods is more limited. What does this paper add? This study provides evidence of inappropriate medicines disposal and potential stockpiling of medicines in Australian households that could contribute to environmental and/or public health risks. It also reveals possible trends towards a higher frequency of inappropriate disposal practices in the Australian context. Insights into respondents’ perceptions of associated risks and awareness of a national scheme for appropriate disposal of medicines have not previously been reported. What are the implications for practitioners? The findings of the present study provide important insights for all health professionals as stakeholders in the quality use of medicines. It is important for those health professionals who assist consumers to manage their medicines to have strategies in place that routinely identify potential stockpiling and inform consumers about appropriate methods of medicines disposal. Although the findings of this study are specific to the Australian context, they may usefully inform policy, public health campaigns and the individual practices of health professionals and other stakeholders in promoting the quality use of medicines nationally and internationally.

2021 ◽  
Vol 14 (6) ◽  
pp. 560
Author(s):  
Pietro Brunetti ◽  
Raffaele Giorgetti ◽  
Adriano Tagliabracci ◽  
Marilyn A. Huestis ◽  
Francesco Paolo Busardò

The rising use of designer benzodiazepines (DBZD) is a cat-and-mouse game between organized crime and law enforcement. Non-prohibited benzodiazepines are introduced onto the global drug market and scheduled as rapidly as possible by international authorities. In response, DBZD are continuously modified to avoid legal sanctions and drug seizures and generally to increase the abuse potential of the DBZD. This results in an unpredictable fluctuation between the appearance and disappearance of DBZD in the illicit market. Thirty-one DBZD were considered for review after consulting the international early warning database, but only 3-hydroxyphenazepam, adinazolam, clonazolam, etizolam, deschloroetizolam, diclazepam, flualprazolam, flubromazepam, flubromazolam, meclonazepam, phenazepam and pyrazolam had sufficient data to contribute to this scoping review. A total of 49 reports describing 1 drug offense, 2 self-administration studies, 3 outpatient department admissions, 44 emergency department (ED) admissions, 63 driving under the influence of drugs (DUID) and 141 deaths reported between 2008 and 2021 are included in this study. Etizolam, flualprazolam flubromazolam and phenazepam were implicated in the majority of adverse-events, drug offenses and deaths. However, due to a general lack of knowledge of DBZD pharmacokinetics and toxicity, and due to a lack of validated analytical methods, total cases are much likely higher. Between 2019 and April 2020, DBZD were identified in 48% and 83% of postmortem and DUID cases reported to the UNODC, respectively, with flualprazolam, flubromazolam and etizolam as the most frequently detected substances. DBZD toxicology, public health risks and adverse events are reported.


Author(s):  
Elham Shahri ◽  
Mohammad Hossein Sayadi ◽  
Elham Yousefi ◽  
Mozhgan Savabieasfehani

2008 ◽  
Vol 25 (4) ◽  
pp. 266-281 ◽  
Author(s):  
Elisia L. Cohen ◽  
Santosh Vijaykumar ◽  
Ricardo Wray ◽  
Ajlina Karamehic-Muratovic

Beverages ◽  
2017 ◽  
Vol 3 (4) ◽  
pp. 54 ◽  
Author(s):  
Francesca Melini ◽  
Valentina Melini ◽  
Francesca Luziatelli ◽  
Maurizio Ruzzi

2018 ◽  
Vol 47 (4) ◽  
pp. 327-336
Author(s):  
Claudia Esmeralda León-López ◽  
José Alfredo Arreola-Lizárraga ◽  
Gustavo Padilla-Arredondo ◽  
Jorge Eduardo Chávez-Villalba ◽  
Renato Arturo Mendoza-Salgado ◽  
...  

Abstract We have examined enterococci concentrations in water and sand (dry and wet) at three semi-arid subtropical recreational beaches to assess public health risks. To determine the concentration of enterococci, water and sand samples were collected before, during and after the Easter Week (when the largest influx of users occurs), and in the wintertime. The lowest concentrations (< 100 MPN 100 ml-1) were recorded before the Easter Week, the highest concentrations (> 1500 MPN 100 ml-1) during and after the Easter Week, and concentrations < 500 MPN 100 ml-1 in the wintertime. Enterococci concentrations in sand were generally < 200 MPN 100 ml-1. Variability in enterococci concentrations can be explained by the influx of users during the Easter Week, rainfall runoff and the increase in water temperature after the Easter Week, as well as by winds and the presence of dogs and birds in the wintertime. The highest health risks occur during and after the Easter Week.


Sign in / Sign up

Export Citation Format

Share Document